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Background: India has generally used 1 TU purified protein derivative (PPD) as opposed to 2 TU PPD globally,
limiting comparisons. It is important to assess latent TB infection in adolescents given that they may be a target
group for new post-exposure TB vaccines.
The aim of this study is to describe the pattern and associations of tuberculin skin test (TST) responses (0.1 ml 2 TU)
in adolescents in South India.
Methods: 6643 school-going adolescents (11 to <18 years) underwent TST. Trained tuberculin reader made the
reading visit between 48 and 96 hours after the skin test
Results: Of 6608 available TST results, 9% had 0 mm, and 12% ≥10 mm responses. The proportion of TST positive
(≥10 mm) was higher among older children, boys, those with a history of TB contact and reported BCG immunization
Those with no TST response (0 mm) included younger participants (<14 years), those whose mothers were illiterate and
those with a recent history of weight loss. Those of a higher socio-economic status (houses with brick walls, LPG gas as
cooking fuel) and those with a visible BCG scar were less likely to be non-responders.
Conclusion: Proportion of non-responders was lower than elsewhere in the world. Proportion of TST positivity was
higher in those already exposed to TB and in children who had been BCG immunized, with a zero response more likely
in younger adolescents and those with recent weight loss.
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In India, large epidemiological studies have used the
tuberculin skin test (TST) to detect tuberculosis (TB)
infection, calculate the annual risk of tuberculous infection
(ARTI) as a measure of the TB transmission in a com-
munity) for different zones of the country, [1] as a
means of evaluating the new case detection rate, and
for monitoring TB case detection efforts of the Revised
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unless otherwise stated.the country [1-3]. ARTI is computed from the preva-
lence of infection estimated after tuberculin skin test
surveys. In India the TST surveys conducted among the
1–9 years age group in the northern India found that
ARTI had declined to 1.1% during 2009 – 10 from 1.9%
during 2000 – 01. In the same surveys the prevalence
of infection was estimated to have declined from 10.1%
to 5.9% [4].
TST data from India has conventionally used a dose of
1TU as opposed to the 2TU dose more universally used
[5,6]. This makes cross-country comparisons with Indian
data difficult. While there are no large data on adoles-
cents in India, the proportion of TST positive children
in India using a cut off of 20 mm is between 5.9% andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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old children between 2000–2003 in Andhra Pradesh, South
India, showed that between 11.6 and 15.5% had no
response (0 mm) [2].
Studies in adolescents are important since they may
constitute a target population for future vaccines in TB,
which aim to prevent active disease in already exposed
populations [8,9] We, therefore conducted this study in
school going adolescents between 11 to 18 years, in
South India, using a dose of 2 TU of PPD – RT 23 with
Tween 80 (Span diagnostics, India), to describe the pat-
terns and socio-demographic and clinical associations
of the proportion of TST positive (>10 mm) and non-
response (0 mm response). In this study 2 TU was used
as the dose. Earlier data by Chadha et al. on BCG
un-vaccinated children in India showed no advantage
of using 2 TU Vs. 1 TU [6]. However, our decision was
based on several considerations. First, the population
of this study were mixed with a large proportion of
BCG vaccinated adolescents including those with BCG
scars (both excluded by Chadha et al.). Second, IUATLD
and WHO guidelines now recommend the use of 2 TU
[10]. Third, Updated Indian Academy of Pediatrics guide-
lines, relevant to at least a part of our study population,
endorse the use of 2 TU [11]. Finally, the intent was to
obtain data that could be compared across countries
(most of which use 2TU).
Methods
Setting
The present analysis is conducted on data derived from
the baseline survey of a prospective cohort of children
and adolescents aged between 11 and 18 years attending
school or junior college. The aim of the cohort study
was to establish the incidence of TB disease during a
follow up of enrolled participants over a 2 year period.
The cohort study was conducted in the Palamaner area
of Chittoor District of Andhra Pradesh in South India
from February 2007 to July 2010. The baseline survey
was completed between February 2007 and May 2008,
the data of which has been used in the present analysis.
The annual total case notification rate of TB in the
district where the study was conducted was 126 per
100,000 and that for India as a country was 132/100,000
during 2007 - 08 [12].
Study design
The present paper is based on a cross-sectional analysis
of data obtained at the baseline survey of the prospect-
ive, cohort study
Subjects
6643 adolescents comprising 3441 boys and 3202 girls
were recruited into the study, after parental consent andadolescent assent. The total number of eligible adoles-
cents was 12,388; the response rate was 53% for boys
and 47% for girls. Participants were excluded if the family
had plans to move from the study area in the 2 years
following enrollment or were unable to attend the
follow-up session for reading of the tuberculin skin test.
Ethics
Written informed assent from the subjects and consent
from the parents/guardians was obtained before the start
of enrollment. The study protocol and informed consent
forms were reviewed & approved by the Institutional
Review Board (IRB) of St John’s Medical College, Bangalore
and by an Independent Ethics Committee (IEC) of Aeras,
USA. The studies were also approved by the Ministry of
Health Screening Committee of the Government of India
(No. 5/8/9/52/2006-ECD-I dt. 10.11.2006).
Assessments
Questionnaires
A detailed clinical history of the child including BCG
immunization status, history of current or past tubercu-
losis, history of close contact of more than 8 hours a
week with an adult with diagnosed tuberculosis during
the last 3 months, and current signs or symptoms of
tuberculosis was recorded from the parents/guardians.
Adolescents were asked to review the same. Socio-
demographic details including the gender and age of the
subjects, parental education, whether they were a mem-
ber of a scheduled caste or scheduled tribe, type of walls
of their home and type of cooking fuel used (as surro-
gates of socio-economic status) and religion were also
recorded during the interview.
Clinical assessments
The presence or absence of a BCG scar was noted.
Weight and height were used to compute Body Mass
Index (BMI) and derive the BMI-for-age z-scores as a
measure of nutritional status using WHO growth refer-
ence (WHO, 2007; Growth reference 5–19 years; calcu-
lated using WHO – ANTHRO software (version 3.2.2)).
Tuberculin skin test
Designated, trained, research nurses administered 0.1 ml
of tuberculin containing 2 TU Purified Protein Deriva-
tive (PPD) of RT 23 with Tween 80 as a stabilizer (SPAN
Diagnostic Ltd, Surat, India), on the anterior surface of
the forearm about 2 to 4 inches below the elbow. A
designated, trained tuberculin reader made the reading
visit between 48 and 96 hours after the skin test was
administered. The skin test site was inspected in good
light. The maximum transverse diameter of the induration
was then measured in millimetres, using a transparent
ruler calibrated in millimetres. The measurements were
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While participants who had responses of 0–4 mm TST
responses received a second TST within 1–4 weeks of the
first and the potential utility of a two-step TST has been
reported earlier [13], the present analysis was restricted to
the first TST result obtained since a two-step TST is not a
standard procedure in India.
Statistical methods
All data collected were entered into customized data
acquisition software using Microsoft SQL for backend
operations. Double data entry and a 100% check of the
data forms were done to assess missing data and clarity
of data prior to data entry. Statistical Package for Social
Sciences Version 17.0 (PASW Statistics, 18.0, SPSS Inc,
Chicago, IL, USA) was used for the analysis of the data.
Chi-square test was used to assess the association of
the proportion of TST positive and Non response with
socio-demographic and clinical variables. Multivariate
analysis was performed using logistic regression to
determine the predictors of the proportion of TST positive
(TST ≥10 mm) and non-response (TST = 0 mm) adjusted
for variables that were significant at the univariate analysis
for both the outcomes separately. When evaluating the
associations of TST non-response i.e. 0 mm, data was
restricted to those who had a TST non response and TST
response of 5 mm or greater. This was done to allow for a
better separation of groups. However, the results did not
qualitatively change when those with a non responses
were compared with all those who had a recordable TSTFigure 1 Flow chart indicating participants who were enrolled into thresponse (TST >0 mm). Since a large number of variables
increases the risk of false positive results the null hypoth-
esis was rejected at P <0.01.
Results
A total of 6643 adolescents were enrolled in the study,
among them TST was administered to 6608 participants
at baseline, 35 participants did not have a TST done;
males and those who had illiterate mothers were more
likely not to have had a TST done. Figure 1 shows a
detailed flow chart of participants who were enrolled
into the study and in whom the TST was administered
and read for the present analysis. There were appro-
ximately equal proportions of girls and boys, and 80%
(N = 5276) of the participants were 14 years or less in
age. The proportion of socio-economically disadvantaged
participants varied based on the parameter used as sum-
marized in Table 1. Reported BCG vaccination was 87.1%
and 62.7% of participants had a visible BCG scar (Table 1).
Among 6608 subjects, 601 (9.1%) had 0 mm, and 794
(12%) > = 10 mm responses respectively. Figure 2 shows
that the distribution of TST responses is similar between
those reported to be BCG immunized compared to
those non – immunized; and between male and female
participants.
The proportion of TST positive was higher in boys
than in girls (AOR 1.19; 95% C.I. 1.02-1.38), in older
participants (AOR 1.69; 95% C.I. 1.16 – 2.47 for 17 –
18 years and AOR 1.31; 95% C.I. 1.04 – 1.65 for 15 –
16 years), in those with a history of contact with TBe study, and in whom the TST was administered and read.
Table 1 Sociodemographic characteristics of the study
participants





11 – 12 years 1778 (26.9)
13 – 14 years 3498 (52.9)
15 – 16 years 1100 (16.6)









Primary or Higher 3411 (51.7)
Education of father*
Illiterate 1724 (26.1)










Unexplained cough ≥2 weeks
Yes 40 (0.6)
No 6568 (99.4)
Unexplained weight loss ≥2 weeks
Yes 27 (0.4)
No 6581 (99.6)















Underweight (<− 2) 1991 (30.2)
Overweight (> +1) 181 (2.7)
Normal (−2 to +1) 4430 (67.1)
TST response
0 mm 601 (9%)
1 – 4 mm 656 (10%)
5 - 9 mm 4557 (69%)
More than or equal to 10 mm 794 (12.0)
Reported as number and within parenthesis column percentages;
*Because data were not available on some individuals total numbers are lower
than the number of subjects who participated in the study
aCumulative response of both parent and subject has been considered in case
of history of past TB, TB exposure, Symptoms suggestive of TB, Past disease
history and past hospital admission.
bIncludes walls made of Packed mud, Stone, Bamboo, Thatch, Wood.
cIncludes Wood, Kerosene, Coal, Agricultural Residue as cooking fuel.
dRecent contact with a TB case at least for 8 hours a week; in the period
of 3 months
eOther symptoms include unexplained Hemoptysis and night sweats
for ≥2 weeks
fWHO cut offs 2007, Growth reference 5–19 years; calculated using WHO –
ANTHRO software (version 3.2.2).
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a reported history of BCG immunization (AOR 1.33;
95% C.I. 1.04 – 1.71). Increased odds were also seen in
those who used LPG gas/electricity as a cooking fuel,
often used as an indicator of relatively higher socio-
economic status (AOR 1.26; 95% C.I. 1.02 – 1.57).
Individuals who were underweight were less likely to be
TST positive on a univariate analysis (OR 0.83; 95% C.I.
0.70 – 0.99), although this was not significant in the
adjusted odds ratio (Table 2).
Those who were more likely to be non responders to
TST, included younger participants (AOR, 0.64; 95% C.I.
0.45 – 0.92 for 15 – 16 years age group and AOR 0.59;
95% C.I. 0.40 – 0.86 for 17 – 18 years group; the refer-
ence group is 11 – 12 years) and those with a recent
unexplained history of weight loss (AOR 7.35; 95% C.I.
3.21 – 16.8). Those who were less likely to be non-
responders included those living in houses with brick
walls (relatively higher socio-economic class; AOR 0.74;
95% C.I. 0.61 – 0.91), living in houses where LPG/Gas
was used as cooking fuel and those with a visible BCG
scar (AOR 0.68; 95% C.I. 0.57 – 0.81). Underweight
participants were more likely to be non-responders on a
univariate (OR 1.23; 95% C.I. 1.03 – 1.48) but not multi-
variate analysis.
X–axis: Tuberculin Skin test responses,divided  
into BCG immunized and non–immunized  
columns
Y–axis: Frequency of participants, divided into  
male and female rows.
Mode of TST response is at 5mm in all  
quadrants.
Figure 2 Distribution of TST in males and females stratified for reported BCG immunization status.
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Our data delineate the pattern of TST responses in
adolescent school-going children in South India. These
data allow for the first comparison with data of other
countries, since 2 TU PPD was used in this study, as
opposed to 1 TU in the earlier studies in India [1,2,7,14].
A small study in India had earlier suggested that TST
reaction sizes were similar with both doses [6]. In the
present study, 9.1% of participants had no response (0 mm)
to the TST, while 12% had a TST response ≥10 mm.
Earlier studies conducted in Andhra Pradesh [2]
showed a proportion of TST positive of about 9.7%, in
younger children and using a higher cutoff of 20 mm at
a 1TU dose. The lower proportion of TST positive (2%
of participants i.e. N = 133) when we use the 20 mm
cutoff in our data set could be because this study was
limited to school-going children who may be healthier
than those in the general population. It is plausible that
we might have found higher TST positive rates, if all
children both school going or school drop-outs were
included. While it may appear contradictory that we
found higher TST positive rates in older children, yet
found lower rates of TST positivity compared to earlier
studies which evaluated younger children, it is important
to emphasise that the first finding reflects a within-studyanalysis while the second, is a cross-study comparison,
where other variables may also have been operative.
The most significant determinants of TST responses
are active or past TB disease [15] and recent exposure to
TB disease [16]. The proportion of TST positive is
associated with TB exposure, with increasing odds of the
proportion of TST positive with increasing proximity of
TB exposure [17,18] with increasing age associated with
an increased likelihood of TB exposure [19-21] and with
male gender[22] These already documented associations
were seen in our study as well. We also showed that
lower socio-economic status was associated with a posi-
tive TST and underweight individuals were less likely to
have a positive TST.
Data from Ghana, where a dose of 2 TU in 0.1 ml
PPD RT23/Tween 80 was used, demonstrated an absence
of a TST response in 41.9% of children with BCG scars
and in 49.1% without BCG scars [23]. In the same study,
TB infection rates using TST responses were shown to be
similar in those with and without a BCG scar, irrespective
of age of the individual [23]. In our study the proportion
of TST positive was slightly higher in the children who
had been BCG immunized compared to who had not
received immunization. This is in contrast to studies
that have indicated that TST results in vaccinated and
Table 2 Sociodemographic, nutritional & clinical associations of the proportion of TST positive using a cutoff
of ≥10 mm
Characteristica TST ≥ 10 mm
(N =7 94) (%)
TST <10 mm
(N = 5814) (%)
P - value OR (95% C.I) Adjusted OR
(95% C.I)
Sex
Male 444 (13.0) 2970 (87.0) 0.01 1.21 (1.05 – 1.41) 1.19 (1.02 – 1.38)
Female® 350 (11.0) 2844 (89.0) 1.00
Age
11 – 12 years® 193 (10.9) 1585 (89.1) 1.00
13 – 14 years 408 (11.7) 3090 (88.3) 0.38 1.08 (0.90 – 1.31) 1.09 (0.90 – 1.31)
15 – 16 years 153 (13.9) 947 (86.1) 0.01 1.33 (1.05 – 1.68) 1.31 (1.04 – 1.65)
17 – 18 years 40 (17.2) 192 (82.8) 0.004 1.71 (1.16 – 2.52) 1.69 (1.16 – 2.47)
Caste
Dalit/Harijan 133 (10.8) 1097 (89.2) 0.15 0.87 (0.71 – 1.05)
Others® 661 (12.3) 4717 (87.7) 1.00
Religion
Hindu 714 (12.2) 5137 (87.8) 0.19 1.18 (0.91 – 1.51)
Others® 80 (10.6) 677 (89.4) 1.00
Education of mother*
Illiterate 372 (11.7) 2818 (88.3) 0.42 0.94 (0.81 – 1.09)
Primary or Greater® 420 (12.3) 2991 (87.7) 1.00
Education of father*
Illiterate 213 (12.4) 1511 (87.6) 0.56 1.05 (0.89 – 1.24)
Primary or Greater® 574 (11.8) 4282 (88.2) 1.00
Walls
Brick 633 (12.1) 4605 (87.9) 0.74 1.03 (0.86 – 1.24)
Others®b 161 (11.8) 1209 (88.2) 1.00
Cooking fuel
LPG/Gas 117 (14.3) 702 (85.7) 0.03 1.26 (1.01 – 1.56) 1.26 (1.02 – 1.57)
Others®c 677 (11.7) 5112 (88.3) 1.00
TB Contact*d
Yes 13 (29.5) 31(70.5) <0.001 3.10 (1.53 – 6.18) 2.88 (1.47 – 5.65)
No® 774 (11.9) 5722 (88.1) 1.00
Unexplained cough ≥2 weeks
Yes 8 (20.0) 32 (80.0) 0.12 1.84 (0.84 – 4.00)
No® 786 (12.0) 5782 (88.0) 1.00
Unexplained weight loss ≥ 2 weeks
Yes 2 (7.4) 25 (92.6) 0.46 0.59 (0.14 – 2.47)
No® 792 (12.0) 5789 (88.0) 1.00
Unexplained fever ≥ 2 weeks
Yes 1 (5.6) 17 (94.4) 0.39 0.43 (0.06 – 3.24)
No® 793 (12.0) 5797 (88.0) 1.00
Other symptomse
Yes 1 (8.3) 11 (91.7) 0.69 0.67 (0.03 – 4.94)
No® 793 (12.0) 5803 (88.0) 1.00
BCG immunization*
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Table 2 Sociodemographic, nutritional & clinical associations of the proportion of TST positive using a cutoff
of ≥10 mm (Continued)
Yes 695 (12.3) 4954 (87.7) 0.01 1.36 (1.06 – 1.74) 1.33 (1.04 – 1.71)
No® 78 (9.3) 757 (90.7) 1.00
BCG Scar
Yes 515 (12.4) 3627 (87.6) 0.18 1.11 (0.95 – 1.30)
No® 279 (11.3) 2187 (88.7) 1.00
BMI - z Score*f
Underweight (<− 2) 212 (10.6) 1779 (89.4) 0.03 0.83 (0.70 – 0.99)
Overweight (> + 1) 26 (14.4) 155 (85.6) 0.46 1.17 (0.75 – 1.82)
Normal (−2 to + 1)® 555 (12.5) 3875 (87.5) 1.00
Reported as number and within parenthesis row percentages; OR: Odds ratio; C.I: Confidence intervals; ® - reference group; P value reported for univariate analysis;
Adjusted odds ratios (Multivariate analysis) were calculated for those characteristics significant in the univariate analysis.
*Because data were not available on some individuals total numbers are lower than the number of subjects who participated in the study
aCumulative response of both parent and subject has been considered in case of history of past TB, TB exposure, Symptoms suggestive of TB, Past disease history
and past hospital admission.
bIncludes walls made of Packed mud, Stone, Bamboo, Thatch, Wood.
cIncludes Wood, Kerosene, Coal, Agricultural Residue as cooking fuel.
dRecent contact with a TB case at least for 8 hours a week; in the period of 3 months;
eOther symptoms include unexplained Hemoptysis and night sweats for ≥2 weeks
fWHO cut offs 2007, Growth reference 5–19 years; calculated using WHO – ANTHRO software (version 3.2.2).
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discrepancy is not immediately clear. BCG vaccination
may affect TST responses [25], although this is likely to be
dependent on the interval between BCG vaccination and
the TST [24,26], and the age at TST [27]. Studies in India,
where 1 TU PPD RT23 was used have indicated that BCG
vaccination does not affect the TST responses in the 5 to
9 year age group [2,28].
The non-responders (i.e. 0 mm) constituted 9.1% of
participants. This proportion is lower than that found
during the ARTI survey conducted by Chadha VK et al.
during 2009 – 10 among 1 to 9 years children in the
South zone of India (16.5% of participants had 0 mm
reaction) [29]. We are unable to explain the differences
between that reported by Chadha and our own data;
however there are several plausible reasons – First, our
study sample was older in age and, possibly therefore,
more exposed to TB. Second, we used 2TU as opposed
to 1TU used in the earlier surveys, this could have
resulted in increased nonspecific (small) TST responses
to, for instance, NTMs, although this is speculative.
Third, our study population was restricted to those in
schools, who could conceivably be more healthy than
the entire population of children, including those out of
school. While a comparison of 1TU and 2 TU tuberculin
surveys are not ideal, given the different distribution
patterns of the responses to these two doses (Chadha et al.)
[6], we believe that reference to earlier work based on
the 1 TU studies is important, since these are the only
large population level data sets available in India.
Our non-response rate is also considerably lower than
that reported in other settings such as Zambia (76%),
South Africa (69%) [30], in local settings such as thecrowded townships of Cape Town, South Africa (50.4%)
[20], and even those in adjacent Bangladesh [31]. However,
rates of HIV prevalence in our study setting were lower
than many of the areas, particularly in Africa. The HIV
prevalence among antenatal clinic attendees in Chittoor
district (the study area) between 2010 – 11, was 0.5% to
1.0% and the prevalence of HIV in Andhra Pradesh state
among adult was 0.90% [32]. Another plausible reason is
that there may be a higher prevalence of NTM’s in parts
of India leading to detectable but small TST responses.
TB infection determined by TST may be underesti-
mated due to the poorer nutritional status in low socio-
economic groups since malnutrition has been associated
with lower TST responses [33]. However, another study
in India did not find this association [14]. Differing indi-
ces of malnutrition across studies adds to the complexity
of interpretation. In our sample, non-response to the
TST was more often found among those with a lower
age, recent unexplained weight loss and those without
BCG scars. Those with objective low weight (using BMI
for age cutoffs) also more often had a TST of 0 mm, but
this was not significant in multivariate analysis (data not
shown). While recent unexplained weight loss, would be
subject to reporting bias and is less objective than
anthropometric measurements, the two parameters also
likely represent different aspects of nutritional status; the
recent loss of weight reflecting a more acute phenomenon,
while the BMI for age cutoff would also include more
chronic nutritional deficits.
Limitations of the study
The study was conducted in school-going children in a
largely rural area of Southern Andhra Pradesh. School
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gender [34]; being female, poverty and economic reasons
were major factors associated with drop-outs [35]. Thus,
our study sample is likely to have had a smaller proportion
of the very poor compared to the general population. This
may have limited our ability to demonstrate the effect of
undernutrition on TST in the multivariate analyses that
we performed. It is also plausible that the proportion of
TST positive rate may be higher than we describe, given
that school-going children may be generally healthier,
although data to support this in this age group are lacking.
Conclusions
Proportion of non-responders was similar than else-
where in India but much lower than elsewhere in the
world and some of them may be false negative, given
the association with unexpected weight loss. Propor-
tion of TST positivity was higher in those who had
been exposed to TB and in children who had been BCG
immunized, while a zero response was more likely in
younger adolescents and those with recent weight loss.
Besides the expected associations higher TST seemed to
be associated with higher SES. Use of LPG/Gas may have
an effect on TST itself, which needs further investigation.
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